vTv Therapeutics (VTVT) Income from Non-Controlling Interests (2015 - 2025)

vTv Therapeutics (VTVT) has 11 years of Income from Non-Controlling Interests data on file, last reported at -$1.6 million in Q3 2025.

• For the quarter ending Q3 2025, Income from Non-Controlling Interests fell 55.82% year-over-year to -$1.6 million; the trailing twelve-month figure through Mar 2026 stood at -$3.0 million (up 29.26% YoY), and the FY2025 full-year result was -$4.1 million, up 3.23% from the prior year.
• Income from Non-Controlling Interests declined to -$1.6 million in Q3 2025, from -$1.3 million in the prior quarter.
• In the past five years, Income from Non-Controlling Interests ranged from a high of -$233000.0 in Q2 2021 to a low of -$2.4 million in Q4 2021.
• A 5-year average of -$1.3 million and a median of -$1.2 million in 2024 frame the typical range for Income from Non-Controlling Interests.
• Peak annual rise in Income from Non-Controlling Interests reached 85.64% in 2021, while the deepest fall reached 605.61% in 2021.
• Tracing VTVT's Income from Non-Controlling Interests over 5 years: stood at -$2.4 million in 2021, then surged by 44.7% to -$1.3 million in 2022, then climbed by 28.4% to -$963000.0 in 2023, then grew by 16.61% to -$803000.0 in 2024, then plunged by 105.11% to -$1.6 million in 2025.
• Business Quant data shows VTVT's Income from Non-Controlling Interests at -$1.6 million in Q3 2025, -$1.3 million in Q2 2025, and -$1.1 million in Q1 2025.